Menu

Filtros : "Suécia" "FMRP-RPP" Removidos: "EEL" "MULHERES" "FMRP-RCO" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia (2019)

    Caldeira-Dias, Mayara; Montenegro, Marcelo F.; Bettiol, Heloisa ; Barbieri, Marco Antonio ; Cardoso, Viviane Cunha ; Cavalli, Ricardo de Carvalho ; Sandrim, Valéria Cristina

    Source: Hypertension Research. Unidade: FMRP

    Subjects: CÉLULAS ENDOTELIAIS, PLASMA, PRÉ-ECLÂMPSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CALDEIRA-DIAS, Mayara et al. Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia. Hypertension Research, v. 42, n. 8, p. 1166-1174, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41440-019-0243-5. Acesso em: 15 jun. 2024.

    • APA

      Caldeira-Dias, M., Montenegro, M. F., Bettiol, H., Barbieri, M. A., Cardoso, V. C., Cavalli, R. de C., & Sandrim, V. C. (2019). Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia. Hypertension Research, 42( 8), 1166-1174. doi:10.1038/s41440-019-0243-5

    • NLM

      Caldeira-Dias M, Montenegro MF, Bettiol H, Barbieri MA, Cardoso VC, Cavalli R de C, Sandrim VC. Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia [Internet]. Hypertension Research. 2019 ; 42( 8): 1166-1174.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1038/s41440-019-0243-5

    • Vancouver

      Caldeira-Dias M, Montenegro MF, Bettiol H, Barbieri MA, Cardoso VC, Cavalli R de C, Sandrim VC. Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia [Internet]. Hypertension Research. 2019 ; 42( 8): 1166-1174.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1038/s41440-019-0243-5

  • Artigo de periodico

    Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial (2016)

    Ruperto, Nicolino; Pistorio, Angela; Oliveira, Sheila; Zulian, Francesco; Cuttica, Ruben; Ravelli, Angelo; Fischbach, Michel; Magnusson, Bo; Sterba, Gary; Avcin, Tadej; Ferriani, Virgínia Paes Leme

    Source: The Lancet. Unidade: FMRP

    Subjects: DERMATOPATIAS, MIOSITE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RUPERTO, Nicolino et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. The Lancet, v. 387, n. 10019, p. 671-678, 2016Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(15)01021-1. Acesso em: 15 jun. 2024.

    • APA

      Ruperto, N., Pistorio, A., Oliveira, S., Zulian, F., Cuttica, R., Ravelli, A., et al. (2016). Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. The Lancet, 387( 10019), 671-678. doi:10.1016/s0140-6736(15)01021-1

    • NLM

      Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Ferriani VPL. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial [Internet]. The Lancet. 2016 ; 387( 10019): 671-678.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/s0140-6736(15)01021-1

    • Vancouver

      Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Ferriani VPL. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial [Internet]. The Lancet. 2016 ; 387( 10019): 671-678.[citado 2024 jun. 15 ] Available from: https://doi.org/10.1016/s0140-6736(15)01021-1
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024